Primary ciliary dyskinesia epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
Line 13: Line 13:
===Incidence===
===Incidence===


*The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
* The estimated incidence of PCD is approximately 1 per 15,000 births
*In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
 
*  


===Prevalence===
===Prevalence===


*The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
* PCD is a rare disorder with an estimated prevalence of 1:10,000
*In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
 
*The prevalence of [disease/malignancy] is estimated to be [number] cases annually.
* The prevalence of PCD is difficult to determine, primarily because of limitations in diagnostic methods that focus on testing ciliary ultrastructure and function.
* Because of lack of appreciation of the cardinal signs and symptoms of infants, there are fewer than 1,000 patients in the United States with the confirmed diagnosis of PCD.


===Case-fatality rate/Mortality rate===
===Case-fatality rate/Mortality rate===

Revision as of 16:18, 4 September 2021

Primary ciliary dyskinesia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Primary ciliary dyskinesia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Interventions

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Primary ciliary dyskinesia epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Primary ciliary dyskinesia epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Primary ciliary dyskinesia epidemiology and demographics

CDC on Primary ciliary dyskinesia epidemiology and demographics

Primary ciliary dyskinesia epidemiology and demographics in the news

Blogs on Primary ciliary dyskinesia epidemiology and demographics

Directions to Hospitals Treating Primary ciliary dyskinesia

Risk calculators and risk factors for Primary ciliary dyskinesia epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Hafsa Ghaffar, M.B.B.S[2]

Overview

Primary ciliary dyskinesia (PCD) is generally documented as etiology of bronchiectasis not only in children or young adults but also in older patients.

It is challenging to demonstrate the prevalence of PCD in diverse population with estimates varying between one in 4000 to one in 40,000.

PCD is linked with the high levels of consanguinity. Clinical suspicion of PCD is high in these communities, chronic cough and nasal symptoms should rise concern for prompt diagnostic testing.

Epidemiology and Demographics

Incidence

  • The estimated incidence of PCD is approximately 1 per 15,000 births

Prevalence

  • PCD is a rare disorder with an estimated prevalence of 1:10,000
  • The prevalence of PCD is difficult to determine, primarily because of limitations in diagnostic methods that focus on testing ciliary ultrastructure and function.
  • Because of lack of appreciation of the cardinal signs and symptoms of infants, there are fewer than 1,000 patients in the United States with the confirmed diagnosis of PCD.

Case-fatality rate/Mortality rate

  • In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
  • The case-fatality rate/mortality rate of [disease name] is approximately [number range].

Age

  • Patients of all age groups may develop [disease name].
  • The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
  • [Disease name] commonly affects individuals younger than/older than [number of years] years of age.
  • [Chronic disease name] is usually first diagnosed among [age group].
  • [Acute disease name] commonly affects [age group].

Race

  • There is no racial predilection to [disease name].
  • [Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].

Gender

  • [Disease name] affects men and women equally.
  • [Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.

Region

  • The majority of [disease name] cases are reported in [geographical region].
  • [Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].

Developed Countries

Developing Countries

References

Template:WH Template:WS